# Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction

> **NCT02564367** · PHASE1,PHASE2 · COMPLETED · sponsor: **AIO-Studien-gGmbH** · enrollment: 30 (actual)

## Conditions studied

- Adenocarcinoma,Stomach
- Adenocarcinoma, Esophagogastric Junction

## Interventions

- **DRUG:** S-1

## Key facts

- **NCT ID:** NCT02564367
- **Lead sponsor:** AIO-Studien-gGmbH
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-06
- **Primary completion:** 2019-03-01
- **Final completion:** 2020-03-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2021-04-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02564367

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02564367, "Feasibility Study of Adjuvant Treatment With S-1 in Patients After R0-Resection of Adenocarcinoma of the Stomach and Esophagogastric Junction". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT02564367. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*